Anti-angiogenic agents—overcoming tumour endothelial cell anergy and improving immunotherapy outcomes

ZR Huinen, EJM Huijbers, JR van Beijnum… - Nature Reviews …, 2021 - nature.com
Immune checkpoint inhibitors have revolutionized medical oncology, although currently only
a subset of patients has a response to such treatment. A compelling body of evidence …
被引用次数：197 相关文章

Anti-angiogenic agents-overcoming tumour endothelial cell anergy and improving immunotherapy outcomes.

ZR Huinen, EJM Huijbers, JR van Beijnum… - Nature reviews …, 2021 - europepmc.org
Immune checkpoint inhibitors have revolutionized medical oncology, although currently only
a subset of patients has a response to such treatment. A compelling body of evidence …

[引用][C] Anti-angiogenic agents—overcoming tumour endothelial cell anergy and improving immunotherapy outcomes

ZR Huinen, EJM Huijbers, JR van Beijnum… - Nature Reviews …, 2021 - cir.nii.ac.jp
Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving
immunotherapy outcomes | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Anti-angiogenic agents-overcoming tumour endothelial cell anergy and improving immunotherapy outcomes

ZR Huinen, EJM Huijbers… - Nature reviews …, 2021 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors have revolutionized medical oncology, although currently only
a subset of patients has a response to such treatment. A compelling body of evidence …

Anti-angiogenic agents—overcoming tumour endothelial cell anergy and improving immunotherapy outcomes

ZR Huinen, EJM Huijbers… - Nature …, 2021 - researchinformation.amsterdamumc …
Immune checkpoint inhibitors have revolutionized medical oncology, although currently only
a subset of patients has a response to such treatment. A compelling body of evidence …